{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T22:57:22Z","timestamp":1687301842639},"reference-count":0,"publisher":"Portico","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dot.2018.54.4.2795154","type":"journal-article","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T11:28:46Z","timestamp":1527247726000},"page":"237","source":"Crossref","is-referenced-by-count":1,"title":["Daclatasvir, asunaprevir and beclabuvir fixed-dose combination for\npatients with genotype 1 chronic hepatitis C"],"prefix":"10.3730","volume":"54","author":[{"family":"Thiam, A.","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Conway, B.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1320","published-online":{"date-parts":[[2018]]},"container-title":["Drugs of Today"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:22:07Z","timestamp":1685452927000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7dddcv2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":0,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1358\/dot.2018.54.4.2795154","relation":{},"ISSN":["1699-4019"],"issn-type":[{"value":"1699-4019","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}